INM
InMed Pharmaceuticals Inc (INM)
Healthcare • NASDAQ • $1.36+3.05%
- Symbol
- INM
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Price
- $1.36
- Daily Change
- +3.05%
- Market Cap
- $7.25M
- Trailing P/E
- N/A
- Forward P/E
- -0.21
- 52W High
- $2.33
- 52W Low
- $0.58
- Analyst Target
- N/A
- Dividend Yield
- 0.00%
- Beta
- 0.93
InMed Pharmaceuticals Inc. operates as a pharmaceutical drug development company in the United States. The company researches and develops cannabinoid-based pharmaceuticals products. Its product candidates include INM-901 for Alzheimer's disease, INM-089 for dry age-related macular degeneration, and INM-755, a cannabinol cream. The company was formerly known as Cannabis Technologies Inc. and changed its name to InMed Pharmaceuticals Inc. in October 2014. InMed Pharmaceuticals Inc. was incorporated in 1981 and is based in Vancouver, Canada.
Company websiteResearch INM on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.